Morgan Stanley’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
|
|||||
|
2025
Q1 | $660K | Sell |
|
|||||
|
2024
Q4 | $724K | Buy |
|
|||||
|
2024
Q3 | $497K | Buy |
|
|||||
|
2024
Q2 | $250K | Buy |
|
|||||
|
2024
Q1 | $323K | Buy |
|
|||||
|
2023
Q4 | $288K | Buy |
|
|||||
|
2023
Q3 | $27.6K | Sell |
|
|||||
|
2023
Q2 | $45.3K | Buy |
|
|||||
|
2023
Q1 | $31.1K | Buy |
|
|||||
|
2022
Q4 | $18.9K | Sell |
|
|||||
|
2022
Q3 | $800K | Sell |
|
|||||
|
2022
Q2 | $1.84M | Sell |
|
|||||
|
2022
Q1 | $2.53M | Sell |
|
|||||
|
2021
Q4 | $3.86M | Buy |
|
|||||
|
2021
Q3 | $478K | Buy |
|
|||||
|
2021
Q2 | $203K | Buy |
|
|||||
|
2021
Q1 | $37K | Buy |
|
|||||
|
2020
Q4 | $27K | Buy |
|
|||||
|
2020
Q3 | $10K | Buy |
|